Uriel Rumbo‐Nava

The PD-L1/PD-1 pathway promotes dysfunction, but not “exhaustion”, in tumor-responding T cells from pleural effusions in lung cancer patients

Heriberto Prado-Garcı́a, Susana Romero‐Garcia, Alejandra Puerto-Aquino et al. · Cancer Immunology Immunotherapy · 2017 · 44 citations · Full text

Medicine, Immunology, Oncology +17

IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma

Lorenzo Islas-Vázquez, Dolores Aguilar‐Cázares, Miriam Galicia-Velasco et al. · Biology · 2020 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.

Luis Vicente Gayosso-Gómez, Gabriela Zárraga-Granados, P Paredes-Garcia et al. · PubMed · 2014 · 16 citations

Medicine, Oncology, Pathology +17

Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.

Heriberto Prado-Garcı́a, Susana Romero‐Garcia, Uriel Rumbo‐Nava et al. · PubMed · 2015 · 15 citations

Life Sciences, Immunology, Oncology +17

Case–control study about magnitude of exposure to wood smoke and risk of developing lung cancer

Renata Báez-Saldaña, Alejandro Rogelio Canseco-Raymundo, Belizario Ixcot-Mejía et al. · European Journal of Cancer Prevention · 2021 · 11 citations

Medicine, Oncology, Cancer Epidemiology +11